Nuclear Receptor Ligands

Mivebresib View larger

Mivebresib

AT3712

CAS 1445993-26-9

More details

Molarity Calculation Cart®

HOW TO ORDER

$45.00

$45.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $20.25 Total: $2,025.00
150 $23.40 Total: $1,170.00
125 $27.45 Total: $686.25
110 $32.40 Total: $324.00
15 $38.25 Total: $191.25

Data sheet

Molecular FormulaC22H19F2N3O4S
Molecular Weight459.47
CAS Numbers1445993-26-9
Storage Condition0C Short Term, -20C Long Term
SolubilityDMSO
Purity98% by HPLC
SMILES CodeO(C1=C(C=2C3=C(C(=O)N(C)C2)NC=C3)C=C(NS(CC)(=O)=O)C=C1)C4=C(F)C=C(F)C=C4
ReferencesAparna Sarthy, et al. Experimental and Molecular Therapeutics. 2016, Abstract 4718.

More info

Mivebresib (ABBV-075), also known as ABBV-075, is a potent BET inhibitor (bromodomain (BRD)-containing protein) with potential antineoplastic activity. Upon administration, the bromodomain inhibitor ABBV-075 binds to the acetyl-lysine binding site in the BRD of certain BRD-containing protein(s), thereby preventing the interaction between those proteins and acetylated histones. This disrupts chromatin remodeling, prevents the expression of certain growth-promoting genes, and leads to an inhibition of cell growth in susceptible tumors. Also a potent inhibitor of MYC and the TMPRSS2-ETS fusion proteins.